VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) Institutional Ownership

CUSIP: 929033108

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
VOR on Nasdaq
Shares outstanding
45,342,050
Price per share
$1.52
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-53,732
Value change
-$2,617,823
Number of holders
0
Price from insider filings
$1.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 20% -37% $13,715,063 -$46,689,509 9,023,068 -77% RA Capital Management, L.P. 12 Mar 2026
5AM Ventures VI, L.P. 3.5% $4,422,863 4,422,863 Andrew J. Schwab 08 Jul 2025
FMR LLC 1.7% -68% $5,231,715 -$10,824,525 2,092,686 -67% FMR LLC 30 Jun 2025
Reprogrammed Interchange LLC 19% -7.5% $1,942,739 -$146,919 1,278,118 -7% Reprogrammed Interchange LLC 14 Oct 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR). This represents 0% of the company’s total 45,342,050 outstanding shares.

Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$2,617,823 $1.52 0
2025 Q3 53,732 $2,617,823 -$140,384,923 $48.72 1
2025 Q2 57,027,241 $91,786,194 -$3,748,602 $1.62 33
2025 Q1 60,090,600 $43,114,461 -$1,211,908 $0.72 44
2024 Q4 60,946,605 $67,648,215 +$16,089,562 $1.11 51
2024 Q3 47,833,717 $33,482,803 -$6,822,922 $0.70 53
2024 Q2 54,508,950 $54,505,939 -$7,830,600 $1.00 68
2024 Q1 58,931,374 $139,665,556 -$1,330,255 $2.37 67
2023 Q4 59,602,163 $134,105,628 -$424,295 $2.25 59
2023 Q3 60,212,841 $127,651,281 -$1,545,105 $2.12 59
2023 Q2 60,773,643 $187,786,679 -$4,690,939 $3.09 70
2023 Q1 60,544,099 $325,727,180 +$1,652,497 $5.38 60
2022 Q4 60,203,525 $400,322,462 +$191,043,574 $6.65 58
2022 Q3 31,535,726 $125,525,000 +$1,428,825 $3.98 45
2022 Q2 31,149,185 $154,807,746 +$417,194 $4.97 45
2022 Q1 30,986,622 $187,160,000 -$1,552,188 $6.04 52
2021 Q4 31,135,859 $361,835,757 -$6,276,146 $11.62 58
2021 Q3 30,687,253 $481,175,720 -$2,456,781 $15.68 51
2021 Q2 30,740,152 $570,752,000 -$868,415 $18.65 49
2021 Q1 30,710,116 $1,311,802,993 +$1,311,802,993 $43.10 48